๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
2800445 66 F VA 10/19/2024 COVID19
COVID19
FLU3
FLU3
COVID19
COVID19
FLUX
FLUX
PFIZER\BIONTECH
PFIZER\BIONTECH
SEQIRUS, INC.
SEQIRUS, INC.
PFIZER\BIONTECH
PFIZER\BIONTECH
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
LM2223
LM2223
388461
388461




Candida infection, Erythema, Fungal infection, Pruritus, Rash; Urticaria; Candid... Candida infection, Erythema, Fungal infection, Pruritus, Rash; Urticaria; Candida infection, Erythema, Fungal infection, Pruritus, Rash; Urticaria; Alopecia, Body temperature, Chills, Headache, Pyrexia; Urticaria; Alopecia, Body temperature, Chills, Headache, Pyrexia; Urticaria More
Patient states that about two hours after vaccinations, she started to experience hives with itchi... Patient states that about two hours after vaccinations, she started to experience hives with itching and redness on the inside of the right arm. She then noticed it on the left arm at a later time, and two days later the rash appeared on her chest. The rash comes and goes, and she is still having issues over five weeks later. Patient went to PCP and was initially treated with an 8 day course of Prednisone 10mg on 9-13-24. When the issue was not resolved as of 9-21-24, she was prescribed a Medrol Dose Pak and Triamcinolone 0.1% Cream at an urgent care clinic. Patient again saw PCP on 10-2-24, and was prescribed a course of Prednisone 10mg. As of 10-18-24, the patient now appears to have developed thrush, and is being treated with Nystatin suspension. Patient also mentioned that the rash/hives tend to flare up in the shower. More
2679669 72 M MD 09/06/2023 RSV
RSV
PFIZER\WYETH
PFIZER\WYETH
HF7708
HF7708
Atrial fibrillation; Atrial fibrillation Atrial fibrillation; Atrial fibrillation
Patient received RSV (Abrysvo) vaccine on 9/2/23 at Pharmacy. Next day after receiving the vaccine... Patient received RSV (Abrysvo) vaccine on 9/2/23 at Pharmacy. Next day after receiving the vaccine, patient called to report of potential Atrial Fibrillation the patient experienced based on the A fib sensor device reader the patient wears. Pharmacist advised patient should follow up with his doctor or go to the emergency room. Patients doctor advised patient to go to the emergency room, where the A Fib event the patient experienced was confirmed. Patient was treated at the emergency room and sent home. Patient is still concerned if he will have a repeat of the A Fib event. Pharmacy is reporting this event. More
2821616 M 01/17/2025 COVID19
PFIZER\BIONTECH

Fatigue, Pyrexia, Rash Fatigue, Pyrexia, Rash
fever; rash; fatigue; This is a spontaneous report received from a Consumer or other non HCP. A mal... fever; rash; fatigue; This is a spontaneous report received from a Consumer or other non HCP. A male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, Manufacturer unknown), for COVID-19 Immunisation. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "fever"; RASH (non-serious), outcome "unknown"; FATIGUE (non-serious), outcome "unknown". Additional information: Patient received the second Pfizer COVID vaccine recently with side effects of fever, rash, and fatigue. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received. More
2821617 F 01/17/2025 PNC20
PFIZER\WYETH

Erythema, Fatigue, Mobility decreased, Pain in extremity, Skin warm Erythema, Fatigue, Mobility decreased, Pain in extremity, Skin warm
for three days her arm hurt quite a lot but then right now can move it but it is still; for three da... for three days her arm hurt quite a lot but then right now can move it but it is still; for three days her arm hurt quite a lot but then right now can move it but it is still/arms movement back but at the site it flared up more; for three days her arm hurt quite a lot but then right now can move it but it is still/arms movement back but at the site it flared up more; redness went away but came back/4 inch round red mark and it is a little more warmer than the rest of the skin; felt tired; This is a spontaneous report received from a Consumer or other non HCP from medical information team, Program ID. A 61-year-old female patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 10Jan2025 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "not recovered", described as "for three days her arm hurt quite a lot but then right now can move it but it is still"; MOVEMENT DISORDER (non-serious), MOBILITY DECREASED (non-serious), outcome "not recovered" and all described as "for three days her arm hurt quite a lot but then right now can move it but it is still/arms movement back but at the site it flared up more"; ERYTHEMA (non-serious), outcome "not recovered", described as "redness went away but came back/4 inch round red mark and it is a little more warmer than the rest of the skin"; FATIGUE (non-serious), outcome "unknown", described as "felt tired". Additional information: Patient noticed today maybe a 4 inch round red mark and it is a little more warmer than the rest of the skin. Originally it was red it seems to go away and patient noticed in the shower, when is feeling it now it is slightly warmer than the rest of arm. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2821618 M NY 01/17/2025 COVID19
COVID19
JANSSEN
PFIZER\BIONTECH


COVID-19, Drug ineffective, SARS-CoV-2 test, Weight; COVID-19, Drug ineffective,... COVID-19, Drug ineffective, SARS-CoV-2 test, Weight; COVID-19, Drug ineffective, SARS-CoV-2 test, Weight More
I've had Covid three times; I've had Covid three times; This is a spontaneous report recei... I've had Covid three times; I've had Covid three times; This is a spontaneous report received from a Consumer or other non HCP, Program ID:. A 71-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; COVID-19 vaccine nrvv ad26 (jnj 78436735) (COVID-19 VACCINE JANSSEN), as dose number unknown, single) for covid-19 immunisation. The patient's relevant medical history included: "kidney cancer" (unspecified if ongoing); "pneumonia" (unspecified if ongoing); "Covid", start date: 2020 (unspecified if ongoing), notes: first one is before the vaccine; "lost twenty pounds" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "I've had Covid three times". The event "i've had covid three times" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Weight: lost twenty pounds. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient tested positive for covid and got a prescription of Paxlovid. The patient had covid 3 times; the first time was before the vaccine. The second time he had it, the patient went to urgent care, and he got Paxlovid for free. The patient felt a lot better than he did the first time he had Covid when he had pneumonia and lost twenty pounds. The patient had covid after Paxlovid. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received. More
2821619 M FL 01/17/2025 COVID19
PFIZER\BIONTECH

Guillain-Barre syndrome Guillain-Barre syndrome
contracted Guillain Barre Syndrome after a Covid Shot; This is a spontaneous report received from a ... contracted Guillain Barre Syndrome after a Covid Shot; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GUILLAIN-BARRE SYNDROME (medically significant), outcome "unknown", described as "contracted Guillain Barre Syndrome after a Covid Shot". The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received. More
2821620 60 F 01/17/2025 COVID19
FLU3
TDAP
UNKNOWN MANUFACTURER
SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
602MF013
UT8506KA
5YB5G
Abscess limb, Acute kidney injury, Sepsis; Abscess limb, Acute kidney injury, Se... Abscess limb, Acute kidney injury, Sepsis; Abscess limb, Acute kidney injury, Sepsis; Abscess limb, Acute kidney injury, Sepsis More
Abscess limb; Acute kidney injury; Sepsis; Initial information received on 06-Jan-2025 regarding an ... Abscess limb; Acute kidney injury; Sepsis; Initial information received on 06-Jan-2025 regarding an unsolicited valid serious Courtesy case received from a consumer/non-healthcare professional. This case involves a 60 years old female patient who said to experienced abscess limb, acute kidney injury and sepsis after receiving Influenza USP trival A-B subvirion no preservative vaccine [Fluzone], Boostrix, Novavax Covid-19 vaccine. The patient's past medical history included Asthma, Tobacco user, Hypertension, Bipolar disorder and Drug hypersensitivity. The patient's past medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing bacterial rhinosinusitis and Fungal skin infection. Concomitant medications included Fluticasone propionate, Salmeterol xinafoate (Advair); Salbutamol (Albuterol); Azelastine, Buprenorphine, Mirtazapine (Mirtazepine Teva); Olanzapine, Oxybutynin, Propranolol and Venlafaxine. On 29-Oct-2024, the patient received a dose of suspect influenza usp trival a-b subvirion no preservative vaccine Suspension for injection lot UT8506KA via intramuscular route in unknown administration site (dose, strength and expiration date: not provided) for drug used for unknown indication and received a dose of suspect novavax covid-19 vaccine injection not produced by Sanofi Pasteur lot 602MF013 via intramuscular route in unknown administration site (dose, strength and expiration date: not provided) for drug used for unknown indication and received a dose 1 of suspect Boostrix not produced by Sanofi Pasteur lot 5YB5G via intramuscular route in unknown administration site (strength and expiration date: not provided) for drug used for unknown indication. On 06-Nov-2024 the patient developed abscess limb, acute kidney injury and sepsis (latency- 8 days). These events was assessed as medically significant and life-threatening and the patient was hospitalized for these events. Action taken- not applicable. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Recovered / Resolved on an unknown date for all the events.; Sender's Comments: Sanofi Company Comment dated 17-Jan-2025: This case involves a 60 years old female patient who said to experienced abscess limb, acute kidney injury and sepsis after receiving Influenza USP trival A-B subvirion no preservative vaccine [Fluzone], Boostrix, Novavax Covid-19 vaccine, with latency of 8 days following vaccination. Further information regarding previous vaccination, tolerance, allergic history, laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, concomitant use of multiple vaccines remains as confounding factor and the role of individual suspect vaccine cannot be assessed. More
โœ“ โœ“
2821639 87 F PA 01/17/2025 RSV
GLAXOSMITHKLINE BIOLOGICALS
75F74
Extra dose administered Extra dose administered
received 2nd dose of Arexvy; This non-serious case was reported by a pharmacist via call center repr... received 2nd dose of Arexvy; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 87-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 75F74, expiry date 31-OCT-2025) for prophylaxis. Previously administered products included Arexvy (received 1st dose on 12-JAN-2024 from batch number PS2CK with expiry date 10-JUL-2025). On 19-DEC-2024, the patient received the 2nd dose of Arexvy. On 19-DEC-2024, an unknown time after receiving Arexvy, the patient experienced extra dose administered (Verbatim: received 2nd dose of Arexvy). The outcome of the extra dose administered was unknown. Additional Information: GSK Receipt Date: 19-DEC-2024 Pharmacist reported that patient received a dose of Arexvy and then was administered with an extra dose of Arexvy, which led to an extra dose administered. The vaccine administration facility was the same as primary reporter. More
2821640 U 01/17/2025 COVID19
UNKNOWN MANUFACTURER

Sudden death Sudden death
Sudden death; This is a spontaneous report received from a Consumer or other non HCP from License Pa... Sudden death; This is a spontaneous report received from a Consumer or other non HCP from License Party. Other Case identifier(s): 2024SA369389 (Sanofi), AE-017381 (BioNTech SE). A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (BNT162B2 OMICRON (KP.2)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SUDDEN DEATH (death, medically significant), outcome "fatal". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. Batch/lot number is not provided, and it cannot be obtained. BNT162b2 omicron (kp.2) is under agreement with BIONTECH SE.; Reported Cause(s) of Death: Unknown cause of death More
โœ“
2821641 32 M IL 01/17/2025 COVID19
PFIZER\BIONTECH
EW0170
Anxiety, Dust allergy, Illness Anxiety, Dust allergy, Illness
Same initial onset of symptoms after vaccine, my anxiety keeps amplifying with symptoms; Very sensit... Same initial onset of symptoms after vaccine, my anxiety keeps amplifying with symptoms; Very sensitive to dust/inhale any amount of dust, get severely sick; Very sensitive to dust/inhale any amount of dust, get severely sick; This is a spontaneous report received from a Consumer or other non HCP. A 33-year-old male patient received BNT162b2 (BNT162B2), on 30Apr2021 as dose 1, single (Lot number: EW0170) at the age of 32 years for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the first administration of BNT162B2. The patient's relevant medical history included: "Gerd" (ongoing); "Sleep apnea" (ongoing); "heart attack/heart issues" (ongoing); "heart attack/heart issues" (ongoing); "Pneumonia" (ongoing). The patient is not allergic to any previous vaccination, medications, food all other products. There were no concomitant medications. The patient was not taking any other medications within 2 weeks prior to the event onset. The following information was reported: ANXIETY (hospitalization), outcome "not recovered", described as "Same initial onset of symptoms after vaccine, my anxiety keeps amplifying with symptoms"; DUST ALLERGY (non-serious), ILLNESS (non-serious), outcome "not recovered" and all described as "Very sensitive to dust/inhale any amount of dust, get severely sick". The event "very sensitive to dust/inhale any amount of dust, get severely sick" required physician office visit. Therapeutic measures were taken as a result of dust allergy, illness. Clinical course: After the vaccine, the patient was very sensitive to dust. If he inhales any amount of dust, he gets severely sick. This resulted to multi-doctor/multi-lung specialists visits and the patient was prescribed with an inhaler (ongoing use). It was also reported that the patient has same initial onset of symptoms after vaccine, his anxiety keeps amplifying with symptoms. The patient's anxiety resulted to hospitalization.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202400329270 same reporter/patient/suspect vaccine; different dose/event; More
โœ“
2821642 F 01/17/2025 COVID19
PFIZER\BIONTECH

Autoimmune disorder, Dermatitis, Post-acute COVID-19 syndrome, Urticaria Autoimmune disorder, Dermatitis, Post-acute COVID-19 syndrome, Urticaria
hyper auto immune system; dermatitis; hives burning, itchy in the body; long term Covid; This is a s... hyper auto immune system; dermatitis; hives burning, itchy in the body; long term Covid; This is a spontaneous report received from a Consumer or other non HCP. A female patient received BNT162b2 (BNT162B2), in 2023 as dsoe number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: AUTOIMMUNE DISORDER (medically significant), outcome "unknown", described as "hyper auto immune system"; DERMATITIS (non-serious), outcome "unknown"; URTICARIA (non-serious), outcome "unknown", described as "hives burning, itchy in the body"; POST-ACUTE COVID-19 SYNDROME (non-serious), outcome "unknown", described as "long term Covid". The event "long term covid" required physician office visit. Clinical course: Caller wanted to report a reaction after vaccines and long term Covid which has been to many doctors they told her she had dermatitis and hyper auto immune system with hives burning, itchy in the body after Covid vaccine 2 years ago. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2821643 58 F NJ 01/17/2025 COVID19
PFIZER\BIONTECH
LM2212
Arthralgia, Neck pain, Peripheral swelling, Product administered at inappropriat... Arthralgia, Neck pain, Peripheral swelling, Product administered at inappropriate site, Ultrasound scan More
Patient states she had arm swelling, neck and shoulder pain and had to see a doctor. She said they c... Patient states she had arm swelling, neck and shoulder pain and had to see a doctor. She said they completed an ultrasound and the vaccine was administered too high and too forward in the arm. Patient was prescriber cyclobenzaprine for the pain. The pain finally just went away after 3 months. More
2821644 56 F OR 01/17/2025 COVID19
PFIZER\BIONTECH
2935465-05780
Fatigue, Influenza like illness, Nasal congestion, Nasopharyngitis, Pain Fatigue, Influenza like illness, Nasal congestion, Nasopharyngitis, Pain
Cold and flu-like symptoms such as stuffy nose, headache, body aches, fatigue, excessively tired, th... Cold and flu-like symptoms such as stuffy nose, headache, body aches, fatigue, excessively tired, that has, so far, lasted 8 days (and counting). More
2821645 24 F WA 01/17/2025 COVID19
PFIZER\BIONTECH

Urticaria Urticaria
I experienced, and am still experiencing chronic hives from the vaccine. I experienced, and am still experiencing chronic hives from the vaccine.
2821646 11 M CA 01/17/2025 COVID19
PFIZER\BIONTECH
LP1776
Incorrect dose administered Incorrect dose administered
Patient received covid vaccines pfizer for 12 yrs + instead of 5yr-11yrs Patient received covid vaccines pfizer for 12 yrs + instead of 5yr-11yrs
2821647 12 M WA 01/17/2025 HPV9
MMR
MNQ
VARCEL
MERCK & CO. INC.
MERCK & CO. INC.
SANOFI PASTEUR
MERCK & CO. INC.
X024650
X008385
U8361AA
Y011017
No adverse event; No adverse event; No adverse event; No adverse event No adverse event; No adverse event; No adverse event; No adverse event
No signs or symptoms of adverse reaction, no treatment required No signs or symptoms of adverse reaction, no treatment required
2821648 45 M 01/17/2025 COVID19
COVID19
MODERNA
MODERNA
020B21A
020B21A
Condition aggravated, Fatigue, Headache, Immune-mediated arthritis, Joint swelli... Condition aggravated, Fatigue, Headache, Immune-mediated arthritis, Joint swelling; Malaise, Neuropathy peripheral, Respiratory tract congestion, Rhinitis More
Since receiving the moderna covid vacccine, my neuropathic symptoms associated with my right ankle (... Since receiving the moderna covid vacccine, my neuropathic symptoms associated with my right ankle (post surgical neuropathy 2016) progressively worsened and ultimately spread bilaterally to my lower back and left foot. These symptoms were accompanied by fatigue, malaise, and persistent joint swelling, headaches, congestion, and rhinitis. i was recently diagnosed with immune related arthritis in those areas and other major joints. None of these neurologic and immune related conditions are conventional and only arose/worsened following the covid vaccination More
โœ“
2821649 56 F IL 01/17/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
FJ917
Infection, Local reaction, Musculoskeletal chest pain, Swelling Infection, Local reaction, Musculoskeletal chest pain, Swelling
PT HAD A LOCAL REACTION . SWELLING ABD UT GOT INFECTED, PT ALSO SAID HER RIBS WERE HURTIN PT HAD A LOCAL REACTION . SWELLING ABD UT GOT INFECTED, PT ALSO SAID HER RIBS WERE HURTIN
2821655 57 M NC 01/17/2025 PNC21
PNC21
MERCK & CO. INC.
MERCK & CO. INC.
Y013009
Y013009
Blood test, Headache, Injection site pain, Nausea, Pyrexia; Vomiting Blood test, Headache, Injection site pain, Nausea, Pyrexia; Vomiting
patient had pain in injection site, headache starting night after vaccination, fever and nausea and ... patient had pain in injection site, headache starting night after vaccination, fever and nausea and vomiting starting that evening. More
2821656 2 M WA 01/17/2025 HIBV
PNC20
MERCK & CO. INC.
PFIZER\WYETH
X022982
HR3650
Injection site erythema, Injection site swelling, Injection site warmth, Letharg... Injection site erythema, Injection site swelling, Injection site warmth, Lethargy, Weight bearing difficulty; Injection site erythema, Injection site swelling, Injection site warmth, Lethargy, Weight bearing difficulty More
Per mother: lethargic, unable to bear weight, swelling and redness at both injection sites, warmth a... Per mother: lethargic, unable to bear weight, swelling and redness at both injection sites, warmth at R thigh. More
2821657 69 F NH 01/17/2025 FLU3
PNC21
SANOFI PASTEUR
MERCK & CO. INC.

Y013009
Feeling hot, Injection site paraesthesia, Injection site pruritus, Injection sit... Feeling hot, Injection site paraesthesia, Injection site pruritus, Injection site warmth, Paraesthesia; Feeling hot, Injection site paraesthesia, Injection site pruritus, Injection site warmth, Paraesthesia More
patient had a reaction to the capvaxive vaccine, came back a few minutes (maybe 5) after the vaccine... patient had a reaction to the capvaxive vaccine, came back a few minutes (maybe 5) after the vaccine and said her arm that she got the capvaxive in started itching at the injection site and getting warm/tingling, then that feeling traveled down her arm, across her chest and to her entire body. She waited by the pharmacy for about a half an hour before she left, she said when she left she did still have the feeling but it was getting better. A few hours later her side effects subsided completely More
2821658 87 M GA 01/17/2025 RSV
GLAXOSMITHKLINE BIOLOGICALS
52z52
Extra dose administered, No adverse event Extra dose administered, No adverse event
Patient previously vaccinated with Arexvy 10/25/2023, and he should not have been vaccinated again. ... Patient previously vaccinated with Arexvy 10/25/2023, and he should not have been vaccinated again. He has experienced no adverse reactions. More
2821659 76 M AR 01/17/2025 RSV
GLAXOSMITHKLINE BIOLOGICALS

Injection site pain Injection site pain
Extreme continuous pain in exact area where injection of vaccine was given. Never had this type of ... Extreme continuous pain in exact area where injection of vaccine was given. Never had this type of problem with any other vaccine ever! More
2821660 54 M NM 01/17/2025 HPV9
MERCK & CO. INC.
y013712
No adverse event, Wrong product administered No adverse event, Wrong product administered
Patient received a Gardasil vaccine that he did not request. No adverse reaction. Patient received a Gardasil vaccine that he did not request. No adverse reaction.
2821661 0.5 F WA 01/17/2025 RV5
MERCK & CO. INC.
2051974
Enema administration, Frequent bowel movements, Haematochezia, Vaccine positive ... Enema administration, Frequent bowel movements, Haematochezia, Vaccine positive rechallenge More
Presented with blood in stool on 1/2. 9 days after getting her 3rd rotavirus vaccine. Parents report... Presented with blood in stool on 1/2. 9 days after getting her 3rd rotavirus vaccine. Parents report they noted change in her stools with increased frequency following the vaccine. This occurred with prior immunization of rotavirus as well. Pt admitted to hospital after 4 attempts at air enema, ultimately successful. More
โœ“ โœ“
2821662 82 M GA 01/17/2025 RSV
GLAXOSMITHKLINE BIOLOGICALS
52z52
Erythema, Extra dose administered Erythema, Extra dose administered
patient got AREXY 2023 - the system didn't upload it to vaccine registry. In 2025 he asked for ... patient got AREXY 2023 - the system didn't upload it to vaccine registry. In 2025 he asked for AREXVY, vaccine registry was checked and wasn't on there so patient was given a second dose. He did not have any adverse events , just some redness on his arm. More
2821663 0.83 M 01/17/2025 COVID19
PFIZER\BIONTECH

No adverse event, Product preparation error No adverse event, Product preparation error
Accidentally diluted COVID 6 mon-4 yrs vaccine with sterile water instead of correct sodium chloride... Accidentally diluted COVID 6 mon-4 yrs vaccine with sterile water instead of correct sodium chloride diluent. Vials were replaced with a different cap by pharmacy and the wrong diluent was grabbed and used. No apparent injury/reaction currently. More
2821664 2 M 01/17/2025 COVID19
PFIZER\BIONTECH

No adverse event, Product preparation error No adverse event, Product preparation error
Accidentally diluted COVID 6 mon-4 yrs vaccine with sterile water instead of correct sodium chloride... Accidentally diluted COVID 6 mon-4 yrs vaccine with sterile water instead of correct sodium chloride diluent. Vials were replaced with a different cap by pharmacy and the wrong diluent was grabbed and used. No apparent injury/reaction currently. More
2821665 3 F 01/17/2025 COVID19
PFIZER\BIONTECH

No adverse event, Product preparation error No adverse event, Product preparation error
Accidentally diluted COVID 6 mon-4 yrs vaccine with sterile water instead of correct sodium chloride... Accidentally diluted COVID 6 mon-4 yrs vaccine with sterile water instead of correct sodium chloride diluent. Vials were replaced with a different cap by pharmacy and the wrong diluent was grabbed and used. No apparent injury/reaction currently. More
2821666 2 M 01/17/2025 COVID19
PFIZER\BIONTECH

No adverse event, Product preparation error No adverse event, Product preparation error
Accidentally diluted COVID 6 mon-4 yrs vaccine with sterile water instead of correct sodium chloride... Accidentally diluted COVID 6 mon-4 yrs vaccine with sterile water instead of correct sodium chloride diluent. Vials were replaced with a different cap by pharmacy and the wrong diluent was grabbed and used. No apparent injury/reaction currently. More
2821667 59 F 01/17/2025 COVID19
PFIZER\BIONTECH
EW0171
Fatigue, Pyrexia, Tinnitus Fatigue, Pyrexia, Tinnitus
FEVERS, FATIGUE - WITHIN 1 DAY - NOTABLE LEFT SIDED TINNITUS THAT HAS NOT RESOLVED NEARLY 4 YEARS LA... FEVERS, FATIGUE - WITHIN 1 DAY - NOTABLE LEFT SIDED TINNITUS THAT HAS NOT RESOLVED NEARLY 4 YEARS LATER. More
2821668 37 F OH 01/17/2025 HPV9
MERCK & CO. INC.

Fatigue, Headache, Myalgia, Pyrexia Fatigue, Headache, Myalgia, Pyrexia
Low grade fever, muscle aches, headache, and fatigue last 5 hours Low grade fever, muscle aches, headache, and fatigue last 5 hours
2821669 77 F GA 01/17/2025 RSV
GLAXOSMITHKLINE BIOLOGICALS
52z52
Extra dose administered, No adverse event Extra dose administered, No adverse event
Received a 2nd dose on 01/14/2025. First dose was on 01/09/2024. Patient has not had any adverse eff... Received a 2nd dose on 01/14/2025. First dose was on 01/09/2024. Patient has not had any adverse effects. More
2821670 12 M PA 01/17/2025 HPV9
HPV9
MERCK & CO. INC.
MERCK & CO. INC.


Dizziness, Fall, Head injury, Headache, Hypoaesthesia; Loss of consciousness, Pa... Dizziness, Fall, Head injury, Headache, Hypoaesthesia; Loss of consciousness, Paraesthesia, Sensory disturbance More
Patient said he couldn?t feel his arm. It felt numb. But he wanted to go home. He started walking to... Patient said he couldn?t feel his arm. It felt numb. But he wanted to go home. He started walking to the front of the office, felt dizzy and passed out almost immediately. He fell and hit his head. His head hurts but no other lasting symptoms. Afterwards he said before he felt dizzy his legs felt tingly, he felt like he was shrinking, and he felt like he was being pushed down. More
2821160 F 01/16/2025 COVID19
FLU3
TDAP
UNKNOWN MANUFACTURER
SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
602MF013
UT8506KA
5YB5G
Abscess limb, Acute kidney injury, Sepsis; Abscess limb, Acute kidney injury, Se... Abscess limb, Acute kidney injury, Sepsis; Abscess limb, Acute kidney injury, Sepsis; Abscess limb, Acute kidney injury, Sepsis More
Sepsis; Abscess limb; Acute kidney injury; This serious case was reported by a consumer via other ma... Sepsis; Abscess limb; Acute kidney injury; This serious case was reported by a consumer via other manufacturer and described the occurrence of sepsis in a 60-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 5YB5G) for prophylaxis. Co-suspect products included Influenza vaccine (Fluzone) (batch number UT8506KA) for prophylaxis and COVID-19 vaccine prot. subunit (NVX CoV 2373) (Novavax COVID-19 Vaccine) (batch number 602MF013) for prophylaxis. The patient's past medical history included asthma, smoker, hypertension and bipolar disorder. Concurrent medical conditions included sinusitis bacterial, fungal dermatitis and drug allergy (BUPROPRION drug allergy). Concomitant products included fluticasone propionate;salmeterol xinafoate (Advair), salbutamol (Albuterol), azelastine, buprenorphine, mirtazapine (Mirtazepine Teva), oxybutynin, propranolol, venlafaxine and olanzapine. On 29-OCT-2024, the patient received the 1st dose of Boostrix (intramuscular), Fluzone (intramuscular) and Novavax COVID-19 Vaccine (intramuscular). On 06-NOV-2024, 8 days after receiving Boostrix and Fluzone, the patient experienced sepsis (Verbatim: Sepsis) (serious criteria hospitalization, GSK medically significant, life threatening and other: serious as per reporter), abscess limb (Verbatim: Abscess limb) (serious criteria hospitalization, life threatening and other: serious as per reporter) and acute kidney injury (Verbatim: Acute kidney injury) (serious criteria hospitalization, GSK medically significant, life threatening and other: serious as per reporter). The outcome of the sepsis, abscess limb and acute kidney injury were resolved. It was unknown if the reporter considered the sepsis, abscess limb and acute kidney injury to be related to Boostrix. The company considered the sepsis, abscess limb and acute kidney injury to be unrelated to Boostrix. Additional Information: GSK Receipt Date: 13-JAN-2025 Patient was received by Novavax on 06-Jan-2025. A 60 year-old Female was vaccinated with Novavax COVID-19 Vaccine, Adjuvanted (2024 - 2025 Formula)(Intramuscular) (LOT: 602MF013) on 29-Oct-2024. The following secondary suspect medications were reported: FLUZONE [INFLUENZA VACCINE](influenza vaccine) and BOOSTRIX(tetanus vaccine toxoid). The following medical history was reported: ASTHMA, SMOKER, HTN, BIOPOLAR D/O, BUPROPRION, BACTERIAL RHINOSINUSITIS and YEAST DERMATITIS. The following concomitant medications were reported: ADVAIR(fluticasone propionate), ALBUTEROL [SALBUTAMOL](salbutamol), AZELASTINE(azelastine), BUPRENORPHINE(buprenorphine), MIRTAZAPINE(mirtazapine), OLANZAPINE(olanzapine), OXYBUTYNIN(oxybutynin), PROPRANOLOL(propranolol) and VENLAFAXINE(venlafaxine). On 06-Nov-2024, on 9 day after vaccination the patient experienced ABSCESS LIMB(Abscess limb)(Serious: Life Threatening and Caused/Prolonged Hospitalization), ACUTE KIDNEY INJURY(Acute kidney injury)(Serious: Life Threatening, Caused/Prolonged Hospitalization and Other Medically Important Condition), SEPSIS(Sepsis)(Serious: Life Threatening, Caused/Prolonged Hospitalization and Other Medically Important Condition). At the time of reporting, the event outcome of Abscess limb was Recovered/Resolved, Acute kidney injury was Recovered/Resolved and Sepsis was Recovered/Resolved.; Sender's Comments: Sepsis, Abscess limb and Acute kidney injury are unlisted events which are considered unrelated to GSK vaccine Boostrix. More
โœ“ โœ“
2821161 30 M MI 01/16/2025 HEPA
GLAXOSMITHKLINE BIOLOGICALS
55M72
Expired product administered Expired product administered
Expired drug used; This non-serious case was reported by a other health professional via call center... Expired drug used; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 30-year-old male patient who received HAV (Havrix) (batch number 55M72, expiry date 13-DEC-2024) for prophylaxis. On 06-JAN-2025, the patient received Havrix (right arm). On 06-JAN-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: Expired Drug Used). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 06-JAN-2025. The medical assistant stated that a patient received an expire dose Havrix on the day of reporting in right arm, which led to expired vaccine used. No reactions to report but reporter had questions on how to proceed. The medical information, phone number and transfer was provided. More
2821179 50 F AZ 01/16/2025 COVID19
COVID19
VARZOS
VARZOS
MODERNA
MODERNA
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS




Bursitis, Electromyogram, Eye irritation, Hypoaesthesia, Magnetic resonance imag... Bursitis, Electromyogram, Eye irritation, Hypoaesthesia, Magnetic resonance imaging; Pain, Paraesthesia, Scan with contrast, Temperature intolerance, Tenosynovitis; Bursitis, Electromyogram, Eye irritation, Hypoaesthesia, Magnetic resonance imaging; Pain, Paraesthesia, Scan with contrast, Temperature intolerance, Tenosynovitis More
Tingling all limbs, mostly RUE. especially digits 1-3 volar Temp sensitivity now. Numbness develop... Tingling all limbs, mostly RUE. especially digits 1-3 volar Temp sensitivity now. Numbness developing. Stinging burning. Tx GABA mg b complex diclofenac oral. Methocarb. Tenosynovitis. Mass. Bursitis. More
2821183 U NY 01/16/2025 PNC15
MERCK & CO. INC.
X011735
Expired product administered, No adverse event Expired product administered, No adverse event
No additional AE/PQC reported.; HCP stated that the VAXNUEVANCE vaccine expired on 01/10/2025 and wa... No additional AE/PQC reported.; HCP stated that the VAXNUEVANCE vaccine expired on 01/10/2025 and was administered to a patient on 01/14/2025.; This spontaneous report was received from a nurse and refers to a patient with unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 14-JAN-2025, the patient was vaccinated with pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) injection, lot #X011735, expiration date: 10-JAN-2025, administered for prophylaxis (strength, dose and route of administration were not provided) (Expired product administered). It was stated that the pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) vaccine did not have any previous temperature excursions. No additional adverse event (AE) reported (No adverse event). Lot# is being requested and will be submitted if received. More
2821184 M WV 01/16/2025 VARZOS
VARZOS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
445TK

Inappropriate schedule of product administration; Inappropriate schedule of prod... Inappropriate schedule of product administration; Inappropriate schedule of product administration More
Shingrix third dose; late second dose of Shingrix; This non-serious case was reported by a pharmacis... Shingrix third dose; late second dose of Shingrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 54-year-old male patient who received Herpes zoster (Shingrix) (batch number 445TK, expiry date 09-AUG-2026) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in NOV-2023). Concurrent medical conditions included stem cell transplant and immunosuppression. On 20-DEC-2024, the patient received the 3rd dose of Shingrix. In OCT-2024, the patient received the 2nd dose of Shingrix. In OCT-2024, not applicable after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: late second dose of Shingrix). On 20-DEC-2024, the patient experienced extra dose administered (Verbatim: Shingrix third dose). The outcome of the drug dose administration interval too long and extra dose administered were unknown. Additional Information: GSK Receipt Date: 20-DEC-2024 and 23-DEC-2024 The pharmacist reported that a patient received third dose of Shingrix, which led to extra dose administered. At the moment of call patient was fine and no reactions. The vaccine administration facility was the same as primary reporter. The patient received an initial dose in November 2023 that facility was unaware of that as it was administered at different facility, after that they administered a second dose in October 2024, which led to drug dose administration interval too long. Health care professional mentioned during the conversation that patient was taking immunosuppressive medication for hematopoietic stem cell transplantation. More
2821187 70 F NC 01/16/2025 FLU3
SEQIRUS, INC.
388487
Injected limb mobility decreased Injected limb mobility decreased
Patient called in January and stated since one week after receiving flu vaccine right arm she has pr... Patient called in January and stated since one week after receiving flu vaccine right arm she has problems with movement in that arm. She is visitng doctor for followup and treatment. More
2821188 0.5 F MA 01/16/2025 DTPPVHBHPB
PNC20
RV5
MSP VACCINE COMPANY
PFIZER\WYETH
MERCK & CO. INC.
U7907AA
HR3650
2037482
Inappropriate schedule of product administration, No adverse event; Inappropriat... Inappropriate schedule of product administration, No adverse event; Inappropriate schedule of product administration, No adverse event; Inappropriate schedule of product administration, No adverse event More
Pt. was given vaccines to early. No adverse reactions. (Vaccine administration error) Pt. was given vaccines to early. No adverse reactions. (Vaccine administration error)
2821189 61 F OH 01/16/2025 VARZOS
VARZOS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
Y7R27
Y7R27
Apathy, Arthralgia, Fatigue, Immediate post-injection reaction, Injection site d... Apathy, Arthralgia, Fatigue, Immediate post-injection reaction, Injection site discomfort; Nausea More
Patient received the vaccine on 12/9 and immediately started feeling some discomfort as the medicati... Patient received the vaccine on 12/9 and immediately started feeling some discomfort as the medication was entering her arm. Patient did not think anything of it because she has had vaccines before, and she has some mild discomfort from it but this 1 did feel little different on the administration of the shingles vaccine. As the day progressed, she started feeling tiredness and nausea and had a little bit of reduced motivation to do her day-to-day tasks because of how she felt. She started experiencing left shoulder tenderness at the site of injection by the time she got home about 30 minutes later. More
2821190 F MN 01/16/2025 COVID19
COVID19
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER


Blood pressure increased, Bradycardia, COVID-19, Dizziness, Electrocardiogram ab... Blood pressure increased, Bradycardia, COVID-19, Dizziness, Electrocardiogram abnormal; Headache, Heart rate decreased, SARS-CoV-2 test positive, Serum ferritin increased, Transferrin saturation increased More
Experienced Bradycardia following the administration of Paxlovid for treatment of Covid-19. Began ta... Experienced Bradycardia following the administration of Paxlovid for treatment of Covid-19. Began taking Paxlovid within 1 day of symptoms and testing positive for Covid-19. I am NOT current on Covid-19 vaccine because I had severe allergic reaction to the booster (3rd dose) and mild reaction after 1st and second doses). The booster caused swelling and hives and blood test results showed elevated levels of iron saturation, and ferritin levels indicating possible hemochromatosis. So, its advised by a healthcare professional that I avoid receiving the Covid-19 vaccine, On day 4 of taking Paxlovid, HR dropped below 39 bpm and experienced dizziness, headache, and lightheadedness, which are still occurring after medication administered was completed on 5. Made an appointment with primary care provider and was given an EKG and it was determined that Bradycardia is present. Blood present was in the hypertension range (150/96) and was told to monitor at home for the next few days as BP is typically in the normal range. If symptoms do not improve within 48 hours, will need ton return to PCP for follow up. More
2821191 70 F CO 01/16/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
BP74J
Condition aggravated, Generalised tonic-clonic seizure Condition aggravated, Generalised tonic-clonic seizure
Patient received 2nd Shingrix vaccine in the afternoon. Patient is on seizure medications but a clon... Patient received 2nd Shingrix vaccine in the afternoon. Patient is on seizure medications but a clonic-tonic seizure had been triggered by the afternoon. Patient knows that this was caused by the vaccine as she experienced a more serious clonic-tonic seizure after receiving the Moderna's COVID-19 vaccine 03/22/2021. More
2821192 44 F OH 01/16/2025 TDAP
GLAXOSMITHKLINE BIOLOGICALS
MC7HK
Injection site erythema, Injection site pain, Injection site swelling, Pain, Pai... Injection site erythema, Injection site pain, Injection site swelling, Pain, Pain in extremity More
Employee (patient) states later that evening noticed increased swelling of left upper arm (smaller t... Employee (patient) states later that evening noticed increased swelling of left upper arm (smaller than the size of a golf ball. Pain and red streaks near injectin site and radiating down to left lower arm. Employee applied ice that evening, took ibuprofen, Benadryl and Zyrtec. Employee reported reaction on 1/16/25 to Nursing supervisor when she returned to work. Employee was sent to Employee Health (per her request for further examination). She does report her Left arm is improving, swelling has decreased and decreased pain. No red streaks noticed going down her left arm, states improved. More
2821193 51 F OH 01/16/2025 VARZOS
VARZOS
VARZOS
VARZOS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS


74NC9
74NC9
Arthralgia, Axillary pain, Mobility decreased, Pain in extremity, Shoulder injur... Arthralgia, Axillary pain, Mobility decreased, Pain in extremity, Shoulder injury related to vaccine administration; Asthenia, Mobility decreased, Nervous system disorder; Arthralgia, Axillary pain, Mobility decreased, Pain in extremity, Shoulder injury related to vaccine administration; Asthenia, Mobility decreased, Nervous system disorder More
Pain in arm, shoulder, armpit and elblow. Unable to lift arm above head or straighten elblow out. S... Pain in arm, shoulder, armpit and elblow. Unable to lift arm above head or straighten elblow out. SIRVA More
2821194 68 M CA 01/16/2025 COVID19
COVID19
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
N/A
N/A
Cardioversion, Resuscitation, Sudden death, Syncope; Cardioversion, Resuscitatio... Cardioversion, Resuscitation, Sudden death, Syncope; Cardioversion, Resuscitation, Sudden death, Syncope More
Sudden death of male likely 67 to 68 at time of his initial inoculations. On 10/29/23 victim collaps... Sudden death of male likely 67 to 68 at time of his initial inoculations. On 10/29/23 victim collapsed while dancing. Ambulance arrived at the scene. He worked in music. I believe he met the criteria of "fully vaccinated" because state mandated these inoculations by August 2021 to attend music events. IMO he was inoculated at clinic. Can't obtain dates, lot, maunfacturer et website DOB-address obtained via online website There is also another report that states different as his DOB. More
โœ“
2821195 49 F PA 01/16/2025 COVID19
COVID19
MODERNA
MODERNA


Asthenia, Chills, Respiratory disorder, Sudden death; Asthenia, Chills, Respirat... Asthenia, Chills, Respiratory disorder, Sudden death; Asthenia, Chills, Respiratory disorder, Sudden death More
Online report of sudden death in female EUA recipient that was weeks away from her birthday. At that... Online report of sudden death in female EUA recipient that was weeks away from her birthday. At that time of inoculations victim was 49-years-old. DOSE#1 Date 03/11/2021 LOT# ? DOSE#2 Date 04/08/2021 Lot# ?. Victim on 04/21/21 made a social media post-that described post Inoculation (of dose#2) adverse events taking place after day 5 fasting until day 13. She stated her adverse events as chills, temp, weakness and breathing. Despite being active on social medica her last post was on 10/11/21. Victim died in her residence according to obituary. There is conflicting data on city-ounty of victim at time of death, social media profile states as home. Online obituary states another location as place of residence. Estimated DOSE#2 date arrived by subtracting 13 days from 04/21/21 as per victims social media post. More
โœ“
2821249 32 F PR 01/16/2025 COVID19
COVID19
COVID19
COVID19
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
FA7484
FA7484
FF2588
FF2588
Anaemia, Condition aggravated, Haemoglobin decreased, Heavy menstrual bleeding, ... Anaemia, Condition aggravated, Haemoglobin decreased, Heavy menstrual bleeding, Hysterectomy; Transfusion, Visual impairment, Vitreous haemorrhage; Anaemia, Condition aggravated, Haemoglobin decreased, Heavy menstrual bleeding, Hysterectomy; Transfusion, Visual impairment, Vitreous haemorrhage More
ANEMIA / LOW HGB / LONG PERIODS WITH LOT OF BLOOD / LOST OF VISION PARTIALLY / HEMORRATIAL VITRIUS ANEMIA / LOW HGB / LONG PERIODS WITH LOT OF BLOOD / LOST OF VISION PARTIALLY / HEMORRATIAL VITRIUS
โœ“ โœ“ โœ“
2821250 61 F IN 01/16/2025 VARZOS
VARZOS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
3J994
3J994
Injection site erythema, Injection site pain, Injection site pruritus, Injection... Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth; Rash More
Injection site became red, hot, sore, itchy, and swollen. A large rash lasted for over a week. I use... Injection site became red, hot, sore, itchy, and swollen. A large rash lasted for over a week. I used an ice pack to help with pain; I also took Tylenol. More